FDA Offers Companies a Remote Checkup Instead of an Inspection
Published Date: 6/26/2025
Notice
Summary
The FDA just released clear guidance on how they’ll do remote regulatory assessments (RRAs) to check on products without visiting in person. This helps companies that make FDA-regulated products by making inspections easier and faster, especially during public health needs. The new rules start now, and businesses should get ready to work with remote checks, which could save time and money.
Analyzed Economic Effects
6 provisions identified: 4 benefits, 1 costs, 1 mixed.
Mandatory records requests expand to devices and BIMO
The guidance aligns with 2022 changes in law (the Food and Drug Omnibus Reform Act of 2022) that added device establishments and sites subject to bioresearch monitoring (BIMO) inspections to FDA's mandatory records-request authority under section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act. The final guidance addresses the Agency's use of section 704(a)(4), including processes for firms to respond.
Electronic records and live data access rules clarified
The guidance clarifies mechanisms for electronic records reviews and the conditions under which FDA might access live data during a remote regulatory assessment, and it addresses concerns about confidentiality and security of establishment information reviewed by FDA. These points explain how and when electronic access to records may be used in RRAs.
FDA issues final RRA guidance
On June 26, 2025, the FDA published a final guidance titled "Conducting Remote Regulatory Assessments—Questions and Answers" that describes the Agency's current thinking on using remote regulatory assessments (RRAs) for FDA-regulated products. The guidance replaces a revised draft from January 26, 2024, and is intended to increase industry understanding of voluntary and mandatory RRAs.
Voluntary vs mandatory RRA participation clarified
The final guidance explicitly distinguishes between mandatory and voluntary RRAs and clarifies how FDA intends to inform establishments of the terms of participation in voluntary RRAs and obtain their consent. This explains the process firms can expect when FDA offers a voluntary remote assessment.
No Paperwork Reduction Act clearance required
The final guidance states it contains no collection of information and therefore does not require clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995. This means the guidance itself does not impose a new OMB information-collection burden.
FDA characterizes guidance as deregulatory
The FDA states that, after considering Executive Order 14192 and OMB guidance M-25-20, it finds this action to be deregulatory in nature. The Agency frames the final guidance as reducing regulatory burden in some manner.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
Previous / Next Documents
Previous: 2025-11753, Carbon and Alloy Steel Threaded Rod From India, Taiwan, Thailand, and the People's Republic of China: Continuation of Antidumping Duty Orders and Countervailing Duty Order
The U.S. is keeping special taxes on steel threaded rods from India, Taiwan, Thailand, and China because stopping them could hurt American businesses. These taxes help stop unfair pricing and unfair government help from those countries. This decision started on June 20, 2025, and means importers will keep paying extra fees to protect U.S. steel makers.
Next: 2025-11757, Homeland Security Advisory Council; Notice of Meeting
The Homeland Security Advisory Council meeting originally set for June 30, 2025, has been moved to July 2, 2025, from 1 to 4 p.m. Eastern Time. Anyone interested must register by June 30 to join the live-streamed event. This change affects attendees but doesn’t impact costs or other meeting details.